Bioverge Ventures reposted this
Proud of the team effort it took to get this partnership over the line. A special shoutout to Jack Castle and Andrew Whittle for leading the deal process, as well as our whole R&D team for developing a thoughtful and ambitious research plan. We look forward to working with Steven S Pullen and the wider Boehringer Ingelheim team to progress regenerative medicines for liver disease patients, a growing and underserved medical need. Onwards and upwards! 💪 Thanks to Ian Johnston at the Financial Times and Lei Lei Wu at Endpoints News for the coverage, below: - https://lnkd.in/e-fAa-Hw - https://lnkd.in/eneR9Jnh
🎉 Announcing our new partnership with Boehringer Ingelheim to discover and develop novel regenerative treatments for chronic liver disease! Our multi-year collaboration will focus on using our proprietary discovery platform – which combines advanced genomics, deep phenotyping and machine learning – and human-organ translational models to accelerate the development of novel targets for undertreated liver diseases, such as late-stage metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis. The deal brings in up to $35m in upfront and near-term milestone payments, with late preclinical, clinical, regulatory and commercial milestones with the potential to exceed $1B, as well as tiered commercial royalties. Chronic liver disease (CLD) and associated cirrhosis accounts for approximately 1 million deaths per year. Currently there are no approved medicines for cirrhosis resulting from CLD and there is an urgent need for new effective treatment options. The partnership is part of Boehringer Ingelheim’s commitment to improving the lives of people living with liver diseases. Together we will continue to pioneer liver regeneration research, with a shared vision of reversing the progression of diseases that affect millions worldwide. Read our full announcement ➡️ https://lnkd.in/ePFjWumn #TeamOchre #biotech #genomics #LiverDisease
The potential to identify drug targets that can drive liver regeneration which are so deeply supported with human evidence is truly an unique opportunity. We look forward to delivering therapies that can drive liver repair through our collaboration with our partners at Ochre Bio!
Well done, Jack O'Meara and Ochre Bio Team. The platform potential of Ochre's innovation represents a significant step forward in addressing a variety of challenging conditions. All the best.
Insanely proud and happy for you and the team at Ochre Bio. Making Ireland proud 🇮🇪🍀 Looking forward to catching up tonight!
Congrats and have a fruitful collaboration unlocking novel treatments for chronic liver diseases!
Congratulations
Thanks Jack. It’s a pleasure to work with a great team at Ochre. I’m very excited to see our partnership get rolling.
Congratulations Jack. Your energy and commitment to making this happen was inspiring and so totally deserved.
Yes yes YES!!! Go Jack O'Meara and huge congrats to you and the whole Ochre team!!!
Great achievement! Have you explored integrating micro-influencers in your next phase to maximize outreach and engagement? Leveraging their authenticity could significantly amplify your message.